Heralding a "step forward on testosterone therapy for men," the FDA announced an initiative to support a potential new indication of low libido in men due to idiopathic hypogonadism. The FDA will Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts BPC 157 and Erectile Dysfunction: What the Evidence Shows and Practical Considerations BPC 157 penis enlargement: What the evidence and real world experience actually show BPC 157 TB 500 Erectile Dysfunction Effects: What Users and Research Actually Report BPC 157 and Erectile Dysfunction: What the Evidence Shows and Practical Considerations